UK Court rles against Lilly in Alimta vitamin regimen patent lawsuit
Eli Lilly announced that the UK High Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would not presently be infringed by Actavis marketing pemetrexed trometamol in the UK, France, Italy and Spain with instructions to dilute the product only with dextrose solution. February 12, 2016